ExploreWatchlistsPricing
  1. JP-listed companies
  2. SUZUKEN CO.,LTD.
  3. Financials
  4. Cash and cash equivalents

SUZUKEN CO.,LTD. (9987)

Market cap
¥424.1B
P/E ratio
12.9x
Suzuken distributes prescription drugs, medical devices and diagnostic products to healthcare providers across Japan through a nationwide network of subsidiaries.
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndCash and cash equivalents (Million JPY)YoY (%)
Mar 31, 2025102,655-43.54%
Mar 31, 2024181,830+66.78%
Mar 31, 2023109,026-22.88%
Mar 31, 2022141,377-6.45%
Mar 31, 2021151,123-9.79%
Mar 31, 2020167,521-21.20%
Mar 31, 2019212,579+9.03%
Mar 31, 2018194,969+80.07%
Mar 31, 2017108,276-0.17%
Mar 31, 2016108,463+6.86%
Mar 31, 2015101,504

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating expenses Operating income Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSDividend payout ratio (%)Dividend per shareEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)
AI Chat